SCHEMBL21323230

SCHEMBL21323230

O=C(/C=C/c1ccc(-c2ccncc2)cc1)N1CC2CN(C(=O)c3ccc4[nH]nnc4c3)CC2C1

nearest known ligand 0.45

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
▸ CHRNB2 P17787 2/20 0.41
▸ CHRNB4 P30926 2/20 0.41
▸ CHRNA3 P32297 2/20 0.41
▸ CHRNA4 P43681 2/20 0.41
▸ CHRNA7 P36544 1/20 0.41
▸ GPR183 P32249 7/20 0.40
▸ GHSR Q92847 1/20 0.37
▸ CCNC P24863 1/20 0.37
▸ CDK8 P49336 1/20 0.37
▸ P4HB P07237 1/20 0.36
▸ ENPP2 Q13822 1/20 0.36
▸ ATXN2 Q99700 1/20 0.36
▸ KCNH2 Q12809 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16961655 1.00 CHRNB2 (0.41) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL16961652 1.00 CHRNB2 (0.41) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL16963353 0.90 MKNK1 (0.44) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL16963359 0.90 MKNK1 (0.44) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL20101593 0.88 CHRNB2 (0.49) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL16963405 0.88 RAB9A (0.42) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL21322924 0.88 RAB9A (0.42) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL16963403 0.88 RAB9A (0.42) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL21322911 0.87 GPR183 (0.42) CHRNB2CHRNB4CHRNA3CHRNA4CHRNA7
SCHEMBL21323334 0.87 GPR183 (0.49) GPR183P4HBENPP2ATXN2KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2900669-B1 HEXAHYDROPYRROLO[3,4-C]PYRROLE DERIVATIVES AND RELATED COMPOUNDS AS AUTOTAXIN (ATX) INHIBITORS AND AS INHIBITORS OF THE LYSOPHOSPHATIDIC ACID (LPA) PRODUCTION FOR TREATING E.G. RENAL DISEASES HOFFMANN LA ROCHE (CH) 2019-09-04 — — EP disclosed
Send feedback